Nasopharyngeal Carcinoma (NPC) Clinical Trials

17 recruiting

Nasopharyngeal Carcinoma (NPC) Trials at a Glance

17 actively recruiting trials for nasopharyngeal carcinoma (npc) are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 3 with 7 trials, with the heaviest enrollment activity in Guangzhou, Nanning, and Nanchang. Lead sponsors running nasopharyngeal carcinoma (npc) studies include Sun Yat-sen University, Ming-Yuan Chen, and Jiangxi Provincial Cancer Hospital.

Browse nasopharyngeal carcinoma (npc) trials by phase

Treatments under study

About Nasopharyngeal Carcinoma (NPC) Clinical Trials

Looking for clinical trials for Nasopharyngeal Carcinoma (NPC)? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Nasopharyngeal Carcinoma (NPC) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Nasopharyngeal Carcinoma (NPC) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Phase 3

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital of Guangxi Medical University266 enrolled1 locationNCT07459296
Recruiting
Phase 3

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma (NPC)
Affiliated Hospital of Guangdong Medical University180 enrolled1 locationNCT07327216
Recruiting
Phase 2

Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial

Nasopharyngeal Carcinoma (NPC)First-line Treatment Failure Nasopharyngeal Carcinoma
Sun Yat-sen University41 enrolled1 locationNCT07101744
Recruiting
Phase 3

Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

Nasopharyngeal Carcinoma (NPC)
Man Hu300 enrolled1 locationNCT07340515
Recruiting
Phase 3

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen456 enrolled12 locationsNCT07328841
Recruiting
Phase 3

Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC

Nasopharyngeal Carcinoma (NPC)
Fudan University462 enrolled6 locationsNCT07303023
Recruiting
Phase 3

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen166 enrolled1 locationNCT07188584
Recruiting
Phase 2

Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)

Nasopharyngeal Carcinoma (NPC)Recurrent Nasopharyngeal Neoplasms
Jiangxi Provincial Cancer Hospital23 enrolled1 locationNCT07277764
Recruiting
Phase 2

A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy

Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech70 enrolled15 locationsNCT06839066
Recruiting
Phase 1Phase 2

SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC

Nasopharyngeal Carcinoma (NPC)
University Medical Center Groningen10 enrolled1 locationNCT06982300
Recruiting
Phase 2

Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma (NPC)
Jiangxi Provincial Cancer Hospital109 enrolled1 locationNCT07085988
Recruiting

An International Study on Pediatric Patients With Rare Tumors.

MesotheliomaThyroid CarcinomaPleuropulmonary Blastoma+11 more
Azienda Ospedaliera di Padova6,250 enrolled1 locationNCT07072143
Recruiting
Phase 3

Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University466 enrolled1 locationNCT06712888
Recruiting
Not Applicable

Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas

ScreeningNasopharyngeal Carcinoma (NPC)Epstein Barr Virus
Ming-Yuan Chen68,649 enrolled1 locationNCT06870435
Recruiting
Not Applicable

Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma (NPC)
The Second Affiliated Hospital of Hainan Medical University24 enrolled1 locationNCT06796270
Recruiting

Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection

Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital, Sun Yat-Sen University700 enrolled1 locationNCT06763289
Recruiting
Phase 1

Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University24 enrolled1 locationNCT06611150